HIGHLIGHTS
- who: The Anti-Histamine Azelastine et al. from the Chinese Academy College, China University California, San Francisco have published the research work: The Anti-Histamine Azelastine, Identi ed by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue, in the Journal: (JOURNAL)
- what: Most importantly, the authors provide evidence that the histamine 1 (H1) receptor blocker azelastine, widely used in allergic rhinitis therapy in a nasal spray formulation, is effective against SARS-CoV-2 infection in several in_vitro assays. The major focus has been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.